TriSalus Life Sciences Inc. (NASDAQ: TLSI) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TRISALUS LIFE SCIENCES INC.

TriSalus Life Sciences Inc. (NASDAQ: TLSI)
Listen to this Section


$3.21
-0.1300 ( -3.90% ) 119.1K

TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.

Market Data


Open $3.21
Previous Close $3.34
Volume 119.1K
Market Cap $204.82M
Day Range $3.14 - $3.39
52 Week Range $2.20 - $7.95
Shares Outstanding 61.42M
Change % -3.90%
Net Change ▼ -0.1300
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2023
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,195,815.00

Date Type Amount Purchased Purchaser
2024-12-19 Buy 62972.00 Frankenius Equity AB
2024-11-25 Buy 5000.00 Wahlstrom Mats
2024-11-22 Buy 2040.00 Wahlstrom Mats
2024-09-13 Buy 7520.00 Szela Mary T
2024-09-12 Buy 5000.00 Szela Mary T
2024-07-02 Sale -74000.00 Desai Arjun JJ
2024-06-05 Sale -35000.00 VON ESCHENBACH ANDREW C.
2024-05-07 Sale -35000.00 Hyveled Liselotte
2024-02-14 Sale -14752.00 Marshak Richard
2024-02-14 Sale -14752.00 Cox Bryan F.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 27, 2025
4 Insider transactions 1 Jun 27, 2025
4 Insider transactions 1 Jun 27, 2025
4 Insider transactions 1 Jun 27, 2025
4 Insider transactions 1 Jun 27, 2025
8-k 8K-related 14 Jun 23, 2025
8-k 8K-related 13 Jun 16, 2025

Latest News


× Before browsing our site, please accept our cookies policy